Know Cancer

or
forgot password

Phenotypic and Genotypic Associations With Symptom Clusters During Childhood Leukemia Treatment


N/A
3 Years
18 Years
Open (Enrolling)
Both
Childhood Leukemia

Thank you

Trial Information

Phenotypic and Genotypic Associations With Symptom Clusters During Childhood Leukemia Treatment


A repeated measures research design will evaluate phenotypic and genotypic treatment-related
symptom associations experienced by children and adolescents 3-17 years of age with a
diagnosis of leukemia.


Inclusion Criteria:



- Phenotypic and genotypic treatment-related symptom associations will be evaluated in
children and adolescents 3-18 years of age with a diagnosis of leukemia.

Exclusion Criteria:

- Children without a definite diagnosis of leukemia will be excluded.

- Children must be able to understand and answer the questions on the questionnaires.

- Children with have a cognitive impairment (e.g. Down syndrome) will not be able to
complete the questionnaires and will not be eligible for the study.

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Principal Investigator

Marilyn Hockenberyy, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Duke University School of Nursing

Authority:

United States: Institutional Review Board

Study ID:

Pro00037891

NCT ID:

NCT01708421

Start Date:

November 2012

Completion Date:

July 2017

Related Keywords:

  • Childhood Leukemia
  • Leukemia
  • Syndrome

Name

Location

Duke University Medical CenterDurham, North Carolina  27710